Literature DB >> 9185208

Recognition of central nervous system metastases in children with metastatic primary extracranial neuroblastoma.

J Blatt1, C Fitz, J Mirro.   

Abstract

In children with primary extracranial neuroblastoma (NB), intrinsic central nervous system (CNS) metastases (brain parenchyma or leptomeninges) are thought to occur rarely. This study was done to evaluate our anecdotal experience, which suggested that CNS involvement is becoming more frequent. Reports of computed tomographic (CT) and magnetic resonance (MR) imaging scans, biopsies, cerebrospinal fluid (CSF) cytologies, and autopsies were reviewed for children with stage IV NB diagnosed in 1978-1993 and followed at the Children's Hospital of Pittsburgh. Of 43 children over the age of 1 year, CNS metastases were documented in 7 (16.2%). Six patients developed signs or symptoms best explained by the presence of CNS tumor and had radiographic and/or histologic evidence of parenchymal disease (cortical masses on CT and MR, n = 3; suprasellar mass on CT, n = 1; diffuse leptomeningeal carcinomatosis by MR and/or autopsy, n = 2). CSF cytologies were positive in the one patient so tested. An additional asymptomatic patient had extensive CNS involvement at autopsy. In two of these children, the CNS was the first or only site of recurrent disease. It is concluded that intrinsic CNS disease is not uncommon in children with NB over the age of 1 year and there has been a trend toward its increasing recognition in recent years. Whether this is a function of wider use of diagnostic tools or a true change in natural history over time with increased intensity of chemotherapy is not clear. A study that prospectively monitors children with advanced neuroblastoma, radiographically and with CSF cytologies (prior to treatment and at 6-monthly intervals), is under way and should help to better define the natural history in the context of current therapies.

Entities:  

Mesh:

Year:  1997        PMID: 9185208     DOI: 10.3109/08880019709009493

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  5 in total

1.  Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.

Authors:  Aleksandra Wieczorek; Joanna Stefanowicz; Marcin Hennig; Elzbieta Adamkiewicz-Drozynska; Marzena Stypinska; Bozenna Dembowska-Baginska; Zuzanna Gamrot; Mariola Woszczyk; Julia Geisler; Tomasz Szczepanski; Szymon Skoczen; Marek Ussowicz; Monika Pogorzala; Szymon Janczar; Walentyna Balwierz
Journal:  BMC Cancer       Date:  2022-06-25       Impact factor: 4.638

2.  PET-CT in detection of meningeal metastasis in neuroblastoma.

Authors:  Madhavi Chawla; Ramamohan Reddy; Rajender Kumar; Chandan J Das; Sandeep Agarwala; Amar M Tiwari; Arun Malhotra; Rakesh Kumar
Journal:  Pediatr Surg Int       Date:  2009-01-08       Impact factor: 1.827

3.  Intracranial metastatic neuroblastoma treated with gamma knife stereotactic radiosurgery: report of two novel cases.

Authors:  Nathan C Rowland; Jennifer Andrews; Daxa Patel; David V Laborde; Adam Nowlan; Bradley George; Claire Mazewski; Andrew Reisner; Howard M Katzenstein
Journal:  Case Rep Neurol Med       Date:  2012-01-19

4.  Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells.

Authors:  Alexander A Goldberg; Adam Beach; Gerald F Davies; Troy A A Harkness; Andréa Leblanc; Vladimir I Titorenko
Journal:  Oncotarget       Date:  2011-10

5.  The choroid plexus may be an underestimated site of tumor invasion to the brain: an in vitro study using neuroblastoma cell lines.

Authors:  Martin März; Michael Karremann; Elodie Vandenhaute; Carolin Stump-Guthier; María Lasierra Losada; Tobias Tenenbaum; Henriette Rudolph; Hiroshi Ishikawa; Christian Schwerk; Horst Schroten; Matthias Dürken
Journal:  Cancer Cell Int       Date:  2015-10-24       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.